Pakistan has nominated Prof. Dr. Shahzad Ali Khan, Vice Chancellor of the Health Services Academy (HSA) Islamabad, to the Policy and Coordination Committee (PCC) of the Special Programme of Research, Development, and Research Training in Human Reproduction (HRP) in Geneva, Switzerland, for the first time in the country’s history, officials said on Thursday.
The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development, and Research Training in Human Reproduction is governed by the Policy and Coordination Committee (PCC) (HRP). According to officials from the National Health Services, Regulations and Coordination (NHS,R&C), Secretary NHS Aamir Ashraf Khawaja has formally nominated Prof. Dr. Shahzad Ali Khan to represent Pakistan in the PCC, as the terms of office of the current two members of the PCC under category 3, Burkina Faso and Uruguay, expire on December 31, 2022.
The PCC has 15 members, and Pakistan has nominated Dr Shahzad Ali Khan VC HSA for this high-level global policy-making international forum based in the World Health Organization’s (WHO) headquarters in Geneva, according to NHS officials. Dr. Shahzad is a leading public health expert with a doctorate degree in management sciences, master’s degrees in finance and public health, and fellowship in public health from the Royal College of Physicians in London.
“Having 28 years of work experience ranging from peripheral level administration to management of tertiary care health facilities, professional expertise of Dr. Shahzad Ali Khan varies varies from health systems analysis, health management, policy planning, strategic planning, governance, health economics and health financing, health reforms, civil society organizations, project management, human resource development of both the public and private sector workforce”, they added.
